Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Shares Issued (2016 - 2025)

AtriCure (ATRC) has disclosed Shares Issued for 16 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Issued rose 144.87% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.9 million, a 479.55% increase, with the full-year FY2025 number at $5.9 million, up 479.55% from a year prior.
  • Shares Issued was $1.3 million for Q4 2025 at AtriCure, up from $392000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $4.6 million in Q1 2021 to a low of -$2.9 million in Q4 2024.
  • A 5-year average of $1.1 million and a median of $457000.0 in 2023 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: plummeted 835.31% in 2024, then skyrocketed 493.94% in 2025.
  • AtriCure's Shares Issued stood at -$1.8 million in 2021, then fell by 5.2% to -$1.9 million in 2022, then surged by 119.99% to $388000.0 in 2023, then tumbled by 835.31% to -$2.9 million in 2024, then skyrocketed by 144.87% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Shares Issued are $1.3 million (Q4 2025), $392000.0 (Q3 2025), and $4.1 million (Q2 2025).